Coexistence of renal cell carcinoma and malignant lymphoma: A causal relationship or coincidental occurrence?

Cancer

Volumn 77, Issue 11, 1996, Pages 2325-2331

  Tihan, Tarik ^a   Filippa, Daniel A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

cancer; incidence; kidney; melanoma; non Hodgkin's lymphoma; renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LUNG CARCINOMA; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, RENAL CELL; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; LIPOMA; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; NEW YORK CITY;

EID: 0030003925     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2325::AID-CNCR22>3.0.CO;2-Y     Document Type: Article

References (27)

1. Whelan SL, Ferlay J. Age specific and standardized incidence rates. In: Parkin DM, editor. Cancer incidence in five continents. vol. VI. IARC Scientific Publication no. 120, Lyon: International Agency for Research on Cancer, 1992:178-81, 303-9, 417-9.
2. Chuang MW, Tzeng CH, Liu JH, Hsieh RK, Liu CJ, Fan S, et al. Second primary cancer in hematological malignancy experience in VGH-Taipei. Chung Hua I Hsueh Tsa Chin (Taiwan) 1989;44(5):325-30.
3. Kingston JE, Hawkins MM, Draper GJ, Marsden HB, Kinnier Wilson LM. Patterns of multiple primary tumours in patients treated for cancer during childhood. Br J Cancer 1987;56(3):331-8.
4. Kobayashi Y, Arimoto H, Watanabe S. Second malignant lymphomas and leukemias in the National Cancer Center from 1962 to 1987. Jpn J Cancer Res 1990;81(6-7):570-7.
5. Lishner M, Slingerland J, Barr J, Panzarella T, Degendorfer P, Sutcliffe S. Second malignant neoplasms in patients with non-Hodgkin's lymphoma. Hematol Oncol 1991;9(3):169-79.
6. Smith MB, Xue H, Strong L, Takahashi H, Jaffe N, Ried H, et al. Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. J Pediatr Surg 1993;28(10):1342-8.
7. Ellis M, Lishner M. Second malignancies following treatment in non-Hodgkin's lymphoma. Leuk Lymphoma 1993;9(4-5):337-42.
8. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, Vaughan Hudson B, MacLennan KA. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationship to host factors, histology and stage of Hodgkin's disease, and splenectomy. Br J Cancer 1993;68(5):1006-11.
9. Travis LB, Curtis RE, Boice JD, Hankey BF, Fraumeni JF Jr. Second cancers following non-Hodgkin's lymphoma. Cancer 1991;67(7):2002-9.
10. Travis LB, Curtis RE, Glimelius B, Holowaty E, Van Leeuwen FE, Lynch CF, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993;85(23):1932-7.
11. Angulo JC, Lopez JI, Zubiaur C, Flores N. Renal carcinoma and non-Hodgkin's lymphoma: a clinical report. Acta Urol Esp 1992;16(7):567-8.
12. Mellemgaard A, Geisler CH, Storm HH. Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur J Haematol 1994;53:218-22.
13. Gutman M, Canaan A, Inbar M, Shafir R, Chaitchik S, Rozin RR, et al. Are malignant melanoma patients at higher risk for a second cancer? Cancer 1991;68(3):660-6.
14. Kantor AF, Curtis RE, Vonderheid EC, vanScott EJ, Fraumeni JF Jr. Risk of second malignancy after cutaneous T-cell lymphoma. Cancer 1989;63(8):1612-5.
15. Frey BM, Morant R, Senn HJ, Fisch T, Schmid U. Simultaneous occurrence of breast carcinoma and malignant lymphoma: case observations and literature review. Schweiz Med Wochenschr 1994;124(23):1010-6.
16. Wagner RF, Pellegrini JR, Delzell E. Decreased risk of subsequent primary noncutaneous malignancies among patients with primary cutaneous melanoma. J Dermatol Surg Oncol 1985;11(11):1097-102.
17. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
18. Statistical Abstract of the United States 1994, U.S. Department of Commerce, Bureau of the Census, 114th ed. Washington, DC. 1994:143.
19. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992;52(suppl):5432-40.
20. Teppo L, Pukkala E, Saxen E. Multiple cancer: an epidemiological exercise in Finland. J Natl Cancer Inst 1985;75(2):207-17.
21. Takebe H, Tatsumi K, Satoh Y. DNA repair and its possible involvement in the origin of multiple cancer. Jpn J Clin Oncol 1985;15(suppl1):299-305.
22. Boice JD Jr., Curtis RE, Kleinerman RA, Flannery JT, Fraumeni JF Jr. Multiple cancers in Connecticut, 1935-82. Yale J Biol Med 1986;59(5):533-545.
23. Muller H, Scott RJ. Tumorsuppressorgen-Mutationen in der Keimbarn: ihre Bedeutung bei familiaren und sporadischen Tumorkrankheit. Sch Med Wochscr 1995; 125:1445-54.
24. Ostenstad B. Soluble interleukin-2 receptor levels in patients with malignant melanoma and renal cell cancer. Acta Oncol 1992;31(4):413-5.
25. Schmidt-Wolf IG, Huhn D, Neubauer A, Wittig B. Interleukin-7 gene transfer in patients with metastatic colon carci noma, renal cell carcinoma, melanoma or with lymphoma. Hum Gene Ther 1994;5(9):1161-8.
26. Dillman RO. The clinical experience with interleukin-2 in cancer therapy. Cancer Biother 1994;9(3):183-209.
27. Igisu K, Seki Y, Oka T, Ohara K, Tamaki K. Four primary malignant tumors including malignant melanoma, and malignant lymphoma in the same adult patient. J Dermatol 1987;14(2):170-4.